Bioventus (BVS) Cash & Equivalents (2020 - 2026)
Bioventus' (BVS) quarterly Cash & Equivalents came in at $35.8 million in Q1 2026, up 57.21% YoY from $22.8 million in Q1 2025, and down 30.04% on a QoQ basis from $51.2 million in Q4 2025.
Bioventus (BVS) Cash & Equivalents (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Cash & Equivalents data on file, last reported at $35.8 million in Q1 2026.
- Quarterly Cash & Equivalents rose 57.21% year-over-year to $35.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.8 million (up 57.21% YoY) and the FY2025 annual result came in at $51.2 million, up 23.22% from the prior year.
- Cash & Equivalents declined to $35.8 million in Q1 2026, from $51.2 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $51.2 million in Q4 2025 to a low of $22.8 million in Q1 2025.
- A 5-year average of $35.3 million and a median of $34.4 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 78.85% — and 2023, when it jumped 72.07%.
- Tracing BVS's Cash & Equivalents over 5 years: stood at $30.2 million in 2022, then climbed by 22.45% to $37.0 million in 2023, then advanced by 12.49% to $41.6 million in 2024, then climbed by 23.22% to $51.2 million in 2025, then tumbled by 30.04% to $35.8 million in 2026.
- The last three Cash & Equivalents figures came in at $35.8 million (Q1 2026), $51.2 million (Q4 2025), and $42.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 29.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 29.46 Mn |
| Mar 28, 2026 | 35.85 Mn |
| Dec 31, 2025 | 51.24 Mn |
| Sep 27, 2025 | 42.16 Mn |
| Jun 28, 2025 | 32.91 Mn |
| Mar 29, 2025 | 22.80 Mn |
| Dec 31, 2024 | 41.58 Mn |
| Sep 28, 2024 | 43.07 Mn |
| Jun 29, 2024 | 31.99 Mn |
| Mar 30, 2024 | 25.17 Mn |
| Dec 31, 2023 | 36.96 Mn |
| Sep 30, 2023 | 26.83 Mn |
| Jul 1, 2023 | 29.39 Mn |
| Apr 1, 2023 | 47.10 Mn |
| Dec 31, 2022 | 30.19 Mn |
| Oct 1, 2022 | 34.36 Mn |
| Jul 2, 2022 | 41.00 Mn |
| Apr 2, 2022 | 27.37 Mn |
| Dec 31, 2021 | 43.93 Mn |
| Oct 2, 2021 | 130.92 Mn |